Effort-based Decision-making and CPAP Adherence
Condition(s) studied
Investigational drug(s) / intervention(s)
Continuous Positive Airway Pressure (CPAP) treatment: Treatment of Obstructive sleep apnoea syndrome with CPAP
Study summary
Obstructive sleep apnoea is the most common sleep disorder in general population, and is often associated with cognitive deficit, mood disorders, hypertension, diabetes mellitus, excessive daytime somnolence, nicturia and an increased cardiovascular and metabolic risk. The gold standard of treatment is Continuous Positive Airway Pressure (CPAP), but the adherence is often poor. The aim of our study is to investigate the effort based-decision making in patients with OSA, pre and post CPAP treatment, as a possible cause of poor adherence.
Eligibility
Primary outcome measure(s)
- Memory — Change will be assesd before starting CPAP and after six months of CPAP treatment
Short and Long-term memory will be assessed with Digit span and California verbal learning test - Executive Function — Change will be assesd before starting CPAPT and after six months of CPAP treatment
attentional and executive functioning will be assessed with Test of Attentional Performance (TAP) - Planning — Change will be assesd before starting CPAPT and after six months of CPAP treatment
Planning will be assessed with Tower of London - Response inhibition — Change will be assesd before starting CPAPT and after six months of CPAP treatment
Will be assessed with Test Go-nogo - Efforth decision making — Change will be assesd before starting CPAPT and after six months of CPAP treatment
Will be assesses with Rapid Serial Visual Presentation (RSVP)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| ICS Maugeri Pavia | Pavia | Italy | Recruiting |
More Istituti Clinici Scientifici Maugeri SpA trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04557293 on ClinicalTrials.gov ↗ ← All trials in Italy